Literature DB >> 3881199

Limitations of tracer oxygen uptake in the canine coronary circulation.

C P Rose, C A Goresky.   

Abstract

Theoretical models of oxygen transport in the myocardium have failed to account for low average tissue pO2 relative to to coronary sinus pO2, measured with pO2 electrodes and myoglobin saturation, and for hypoxic contractile failure at relatively high coronary sinus pO2 levels. These findings could be explained by either arteriovenous diffusional shunting or a limiting rate of transfer of oxygen from blood to tissue, or both. To gain new insights, we performed multiple indicator dilution tracer experiments across the coronary circulation in the dog, with 18O2 as the oxygen tracer and 51Cr-labeled red cells as the reference tracer for oxygen. 125I-Albumin and 22Na+ were included to provide the relative plasma flow rate. The tracer oxygen outflow curve consisted of a large early peak related to its reference red cell curve. No tracer emerged before the labeled red cells. The downslope, which contains the returning component of the tracer curve, decreased less steeply when oxygen consumption was reduced by propranolol. Fitting the tracer oxygen outflow curve with a distributed model including irreversible sequestration behind a resistance gave a transfer rate constant which was relatively small, and a relatively large rate constant for sequestration. Relative oxygen consumption (estimated from the arteriovenous difference) correlated closely with the rate constant for sequestration. Estimated average tissue oxygen concentrations were of the order of one-third blood concentration. Dimensional analysis indicates that the low transfer rate constant derives from hemoglobin-oxygen binding; this decreases fractional tracer oxygen transfer in proportion to the ratio of plasma:red cell oxygen pools.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881199     DOI: 10.1161/01.res.56.1.57

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  14 in total

1.  A computational model of oxygen transport from red blood cells to mitochondria.

Authors:  Richard P Beyer; James B Bassingthwaighte; Andreas J Deussen
Journal:  Comput Methods Programs Biomed       Date:  2002-01       Impact factor: 5.428

Review 2.  The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.

Authors:  David G Le Couteur; Robin Fraser; Sarah Hilmer; Laurent P Rivory; Allan J McLean
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Microcirculatory considerations in NMR flow imaging.

Authors:  J B Bassingthwaighte
Journal:  Magn Reson Med       Date:  1990-05       Impact factor: 4.668

4.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

5.  In vivo comparison of non-gaseous metabolite and oxygen transport in the heart.

Authors:  C P Rose; C A Goresky; G G Bach; J B Bassingthwaighte; S Little
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

Review 6.  Through the microcirculatory maze with machete, molecule, and minicomputer (1986 Alza lecture).

Authors:  J B Bassingthwaighte
Journal:  Ann Biomed Eng       Date:  1987       Impact factor: 3.934

7.  Simultaneous blood-tissue exchange of oxygen, carbon dioxide, bicarbonate, and hydrogen ion.

Authors:  Ranjan K Dash; James B Bassingthwaighte
Journal:  Ann Biomed Eng       Date:  2006-05-30       Impact factor: 3.934

8.  Modeling [15O]oxygen tracer data for estimating oxygen consumption.

Authors:  A Deussen; J B Bassingthwaighte
Journal:  Am J Physiol       Date:  1996-03

9.  Diffusional shunting of oxygen in saline-perfused isolated rabbit heart is negligible.

Authors:  J H van Beek; G Elzinga
Journal:  Pflugers Arch       Date:  1987-10       Impact factor: 3.657

Review 10.  The concept of a critical oxygen delivery.

Authors:  P T Schumacker; S M Cain
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.